Literature DB >> 26832190

The roles of interferons in osteoclasts and osteoclastogenesis.

Qi Xiong1, Lihai Zhang1, Wei Ge2, Peifu Tang3.   

Abstract

Interferons (IFNs) play essential roles in regulating osteoclast differentiation and bone resorption. Over the last decade, we have seen tremendous developments in our understanding of the mechanisms by which interferons regulate osteoclastogenesis. Of the type I interferons, IFN-β inhibits osteoclastogenesis via autoregulatory or exogenous regulatory mechanisms, while IFN-α was recently shown to participate in regulating osteoclast formation. And the only member of type II interferons, IFN-γ, has biphasic effects on osteoclastogenesis. Type III interferons have also been shown to be involved in osteoclast bone resorption, although no direct regulatory mechanism has been demonstrated. In this review, we provide an update account of the current knowledge on these recently revealed novel roles of interferons in the regulation of a variety of signaling pathways in osteoclast differentiation and function. The potential clinical applications are also discussed.
Copyright © 2015 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Interferon; Osteoclast; Osteoclastogenesis; Osteolytic diseases

Mesh:

Substances:

Year:  2016        PMID: 26832190     DOI: 10.1016/j.jbspin.2015.07.010

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  9 in total

1.  Tumor necrosis factor receptor-associated factor 6 is required to inhibit foreign body giant cell formation and activate osteoclasts under inflammatory and infectious conditions.

Authors:  Akihito Oya; Eri Katsuyama; Mayu Morita; Yuiko Sato; Tami Kobayashi; Kana Miyamoto; Toru Nishiwaki; Atsushi Funayama; Yoshinari Fujita; Takashi Kobayashi; Morio Matsumoto; Masaya Nakamura; Arihiko Kanaji; Takeshi Miyamoto
Journal:  J Bone Miner Metab       Date:  2017-12-22       Impact factor: 2.626

Review 2.  Type I interferon in rheumatic diseases.

Authors:  Theresa L Wampler Muskardin; Timothy B Niewold
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

Review 3.  Regulation of Osteoclast Differentiation by Cytokine Networks.

Authors:  Dulshara Sachini Amarasekara; Hyeongseok Yun; Sumi Kim; Nari Lee; Hyunjong Kim; Jaerang Rho
Journal:  Immune Netw       Date:  2018-02-07       Impact factor: 6.303

4.  Effects of rheumatoid arthritis associated transcriptional changes on osteoclast differentiation network in the synovium.

Authors:  Shilpa Harshan; Poulami Dey; Srivatsan Ragunathan
Journal:  PeerJ       Date:  2018-10-11       Impact factor: 2.984

5.  The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss.

Authors:  Ting Zheng; Ju-Hee Kang; Jung-Sun Sim; Jung-Woo Kim; Jeong-Tae Koh; Chan Soo Shin; Hyungsik Lim; Mijung Yim
Journal:  Oncotarget       Date:  2017-08-28

6.  Clonal Analysis Delineates Transcriptional Programs of Osteogenic and Adipogenic Lineages of Adult Mouse Skeletal Progenitors.

Authors:  Maria Rostovskaya; Samantha Donsante; Benedetto Sacchetti; Dimitra Alexopoulou; Sylvia Klemroth; Andreas Dahl; Mara Riminucci; Paolo Bianco; Konstantinos Anastassiadis
Journal:  Stem Cell Reports       Date:  2018-06-21       Impact factor: 7.765

Review 7.  Interferon-Gamma-Mediated Osteoimmunology.

Authors:  Mengjia Tang; Li Tian; Guojing Luo; Xijie Yu
Journal:  Front Immunol       Date:  2018-06-29       Impact factor: 7.561

Review 8.  Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System.

Authors:  Marco Ponzetti; Nadia Rucci
Journal:  Front Endocrinol (Lausanne)       Date:  2019-04-18       Impact factor: 5.555

Review 9.  Interleukin-17A Interweaves the Skeletal and Immune Systems.

Authors:  Mengjia Tang; Lingyun Lu; Xijie Yu
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.